Personalized Health and Related Technologies (PHRT) is a strategic focus area of the ETH Domain which encompasses six Swiss institutions: ETHZ, EPFL, PSI, Empa, Eawag and WSL. The main goal of PHRT is to drive the ongoing life science revolution that will ultimately transform medicine as it is today into ‘individualized medicine’. In essence, a person’s unique biological makeup will guide decisions on how to maintain and restore health. Thanks to its community of researchers and associated hospitals, PHRT is pushing the frontiers of knowledge on the mechanisms of diseases and opening the door to new treatments and technologies improving health and disease treatments.
On January 28th, join us for an exclusive event hosted by the PHRT Main in collaboration among others with Molly Shoichet, Scientific Director of PRiME at the University of Toronto.
The ETH PHRT Swiss Multi-Omics Center and the University Children’s Hospital Zurich are excited to announce that they have received a Horten Consortium Project for Clinical Translation (CONPRO) grant of
The ‘Data for Health’ symposium attracted a large audience: over 450 people from medicine, academia, industry and politics came together to celebrate the successes of PHRT and SPHN
